Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Multicenter Study of Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors (CLOVER)

NCT03509012 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03509012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Multicenter Study of Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors (CLOVER)
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
May 2, 2018
Completion date
January 8, 2025
Enrollment
105 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, carcinoma, squamous cell of head and neck, small cell lung carcinoma